Farms.com Home   News

APAS Releases Report On Impacts Of Carbon Tax

In December, Ottawa announced more increases for the federal carbon tax that would see it reach $170 per tonne by 2030.
 
The Agricultural Producers Association of Saskatchewan has done some number crunching on just what that will mean for farmers.
 
President Todd Lewis says when you look at the costs associated with growing wheat, that would put the cost at over $12.50 an acre in 2030 due to the carbon tax.
 
"It's really going to affect the sustainability of the industry long-term if we see these increased costs passed 100% on to producers. It's going to make investing in new technologies and improving our carbon footprint, it will make it more difficult to do that. So, it's really counterintuitive to what they're trying to establish here with these changes."
 
Lewis notes these costs would be even higher in years like 2019, when most of the grain and oilseed crops required grain drying due to a wet harvest.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.